A New Mutation in IDS Gene Causing Hunter Syndrome: A Case Report
- PMID: 32256517
- PMCID: PMC7093562
- DOI: 10.3389/fgene.2019.01383
A New Mutation in IDS Gene Causing Hunter Syndrome: A Case Report
Abstract
Rationale: Mucopolysaccharidosis type II (Hunter syndrome) is an X-linked multisystem disorder, caused by deficiency of the lysosomal enzyme iduronate-2-sulfatase (I2S). The clinical manifestations of this disease are severe skeletal deformities, airway obstruction, cardiomyopathy, and neurologic deterioration.
Patient: The patient was 5 years and 6 months boy, with developmental delay, hearing loss, hepatosplenomegaly, and skeletal dysplasia. He was diagnosed with mucopolysaccharidosis type II based on clinical manifestations, biochemical and genetic analysis.
Outcomes: The patient carries a new mutation (c.879-1210_1007-218del) in hemizygosis in the IDS gene, which was defined as pathogenic according to the 2015 American College of Medical Genetics and Genomics-Association for Molecular Pathology guidelines and as responsible for the mucopolysaccharidosis type II phenotype in the patient.
Keywords: Hunter syndrome; IDS; iduronate-2-sulfatase; inborn errors of metabolism; lisossomal storage disease; mucopolysaccharidosis type II.
Copyright © 2020 Gomes, Marins, Motta, Kyosen, Curiati, D’Almeida, Martins and Pesquero.
Figures
References
-
- Amiñoso C., Vallespin E., Fernández L., Arrabal L. F., Desviat L. R., Pérez B., et al. (2013). Identification of the first deletion–insertion involving the complete structure of GAA gene and part of CCDC40 gene mediated by an Alu element. Genetics 519, 169–172. - PubMed
-
- Birot A. M., Bouton O., Froissart R., Maire I., Bozon D. (1996). IDS Gene-Pseudogene exchange responsible for an intragenic deletion in a hunter patient. Hum. Mutat. 8, 844–850. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
